Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia

Indian Journal of Dermatology, Venereology and Leprology

Volumn 75, Issue 1, 2009, Pages 47-51

  Hajheydari, Zohreh ^a   Akbari, Jafar ^a   Saeedi, Majid ^a   Shokoohi, Leila ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Androgenetic alopecia; Finasteride; Topical gel

Indexed keywords

FINASTERIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; FOLLOW UP; HUMAN; MALE; MALE TYPE ALOPECIA;

ADMINISTRATION, TOPICAL; ADULT; ALOPECIA; CHEMISTRY, PHARMACEUTICAL; DOUBLE-BLIND METHOD; FINASTERIDE; GELS; HUMANS; MALE; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59249100081     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.45220     Document Type: Article

References (17)

1. Price VH, Menefee E, Sanchez M, Ruane P, Kaufman KD. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, and daily. J Am Acad Dermatol 2002;46:517-23.
2. Dunlop F. Androgenetic alopecia in men and women: An overview of cause and treatment. 2005. Available from: http://www.folicle.com\section2\2.html.
3. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47:377-85.
4. Hugo Perez BS. Ketokonazole as an adjunct of finasteride in the treatment of androgenetic alopecia in men. Med Hypotheses 2004;62:112-5.
5. Sintova A, Serafimovich S, Gilhar A. New topical ant androgenic formulation can stimulate hair growth in human bald scalp grafted onto mice. Int J Pharm 2000;194:125-34.
6. Vexiau P, Chaspoux C, Boudou P, Fiet J, Jouanique C, Hardy N, et al. Effects of minoxidil 2% versus cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial. Br J Dermatol 2002;146:992-9.
7. Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia (Male pattern hair loss). J Investig Dermatol Symp Proc 2003;8:20-3.
8. Shokree J, Javadzadeh Y, Aayatollahi M, Asnaashari S, Mateen A. Local finasteride formulation and assessment of its dermal absorption. Drug Sci 2004;1:97-106.
9. Lucas KJ. Finasteride cream in hirsutism. Endocr Pract 2001;7:5-10.
10. Mazzarella F, Loconsole F, Cammisa A, Mastrolonardo M, Vena GA. Topical finasteride in the treatment of androgenetic alopecia: Preliminary evaluation after a 16-month therapy course. J Dermatol Treatment 1997;8:189-92.
11. Hajheydari Z, Jamshidi M, Akbari J, Mohammadpour R. Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: A double-blind randomized controlled study. Indian J Dermatol Venereol Leprol 2007;73:29-32.
12. Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL. The effect of Finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydro-testosterone concentration in patients with male pattern baldness. J Clin Endocrinol Metab 1994;79:703-6.
13. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia: Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578-89.
14. Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, et al. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 1999;41:555-63.
15. Hamilton JB. Drug category. Available from: http://www.emedicine.com/ derm/topic21.htm. [cited on 2003].
16. Burkhart CG, Burkhart CN. 5 alpha reductase and finasteride in pattern alopecia and acne. J Drug Dermatol 2004;3:363-4.
17. Altomare G. Capella G. Depression circumstantially related to the administration for androgenetic alopecia. J Dermatol 2002;29:665-9.